Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
100%
Post-acute Sequelae of SARS-CoV-2 Infection
100%
Antihyperglycemic
100%
Metformin
55%
Dipeptidyl peptidase-4 (DPP-4)
33%
Risk Ratio
33%
Risk Difference
33%
Sulfonylurea
33%
Risk Reduction
22%
Predicted Probability
22%
United States
11%
Illness
11%
Effectiveness Evaluation
11%
Electronic Health Record Data
11%
Confidence Interval
11%
Machine Learning Algorithms
11%
COVID-19 Diagnosis
11%
Severe COVID-19
11%
Diagnostic Codes
11%
Therapy Efficacy
11%
Care Relationship
11%
Probability-based
11%
Patient-level
11%
Clinical Definition
11%
Outcome Definition
11%
Health Institutions
11%
ML Algorithms
11%
Difference in Mean
11%
De-identified
11%
Coronavirus Disease (COVID)
11%
Medicine and Dentistry
Infection
100%
Maturity Onset Diabetes of the Young
100%
Drug Therapy
100%
Sequela
100%
Patient with Type 2 Diabetes
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Glycon
55%
Dipeptidyl Peptidase-4 Inhibitor
33%
Attributable Risk
33%
Sulfonylurea
33%
COVID-19
22%
Disease
11%
Electronic Health Record
11%
Outpatient
11%
Identified Patient
11%
Diagnosis Code
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Infection
100%
SARS Coronavirus
100%
Metformin
55%
Sulfonylurea
33%
Dipeptidyl Peptidase IV Inhibitor
33%
Disease
11%